We are live on
!
Find out more
EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
17 hedge funds and large institutions have $12.9M invested in Eucrates Biomedical Acquisition Corp. Unit in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
11% less funds holding
Funds holding: 19 → 17 (-2)
30% less capital invested
Capital invested by funds: $18.4M → $12.9M (-$5.45M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$786K |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$26.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$993 |
